Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06716_nanopub.RArWmSkRKVZhanq5w89C6GN_Dl2NdT1RiqD80wTR1s0KQ#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB06716 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06716 label "Fospropofol [drugbank:DB06716]" assertion.
- drugbank:DB06716 seeAlso DB06716 assertion.
- drugbank:DB06716 seeAlso fospropofol.html assertion.
- drugbank:DB06716 seeAlso lusedra-drug.htm assertion.
- drugbank:DB06716 identifier "drugbank:DB06716" assertion.
- drugbank:DB06716 description "Fospropofol is a water soluble prodrug and is converted to propofol in the liver. Fospropofol is a short acting hypnotic/sedative/anesthetic agent. Unlike propofol, does not cause injection-site pain as it is unable to activate TRPA1. FDA approved in December 2008. Fospropofol is classified as a Schedule IV controlled substance in the United States' Controlled Substances Act." assertion.
- drugbank:DB06716 title "Fospropofol" assertion.
- drugbank:DB06716 bio2rdf_vocabulary:identifier "DB06716" assertion.
- drugbank:DB06716 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06716 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06716" assertion.
- drugbank:DB06716 bio2rdf_vocabulary:x-identifiers.org DB06716 assertion.
- drugbank:DB06716 drugbank_vocabulary:drugbank-id "DB05279" assertion.
- drugbank:DB06716 drugbank_vocabulary:drugbank-id "DB06716" assertion.
- drugbank:DB06716 drugbank_vocabulary:x-cas cas:258516-87-9 assertion.
- drugbank:DB06716 drugbank_vocabulary:x-ahfs ahfs:28:04.92 assertion.
- drugbank:DB06716 drugbank_vocabulary:x-kegg kegg:D04257 assertion.
- drugbank:DB06716 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165958389 assertion.
- drugbank:DB06716 drugbank_vocabulary:x-wikipedia wikipedia:Fospropofol assertion.
- drugbank:DB06716 drugbank_vocabulary:x-ndc ndc:62856-350-08 assertion.